Use of an Electronic Medical Record to Improve Standard Practice in the Primary Care Setting: A Randomized-Controlled Study of Herpes Zoster Vaccination Rates

Use of an Electronic Medical Record in the Primary Care Setting to Improve Herpes Zoster Vaccination Rates

Sponsors

Lead sponsor: Ohio State University

Source Ohio State University
Brief Summary

Despite the significant benefits of herpes zoster vaccine (HZV), vaccination rates remain low. Electronic medical records (EMR) can serve as a practical strategy to better facilitate the application of preventative health care, such as increasing immunization rates. A new care model that can increase the herpes zoster vaccination rate, as well as other preventative health services, is warranted. The objective of this study is to investigate if the functions of an EMR, in combination with a pharmacist as part of the care team, can improve the herpes zoster vaccination rate.

Overall Status Completed
Start Date March 2011
Completion Date December 2011
Primary Completion Date December 2011
Phase N/A
Study Type Interventional
Primary Outcome
Measure Time Frame
Number of Participants Who Received the Herpes Zoster Vaccine 6 months
Secondary Outcome
Measure Time Frame
Difference in Vaccination Rates Between Patients Who Recieved a Mailed Letter Versus a Secure Email 6 months
Amount of Time Required by a Clinical Pharmacist to Manage This Workflow 6 months
Enrollment 2589
Condition
Intervention

Intervention type: Other

Intervention name: An informational packet regarding shingles and the HZV was sent to patients identified by the EMR

Description: The EMR generated a list of patients aged 60 or older without HZV documentation. Patients were categorized into two subgroups based on activated electronic patient portal (EPP) status. Randomized patients from each subgroup received an informational packet regarding shingles and the HZV by either the EMR or USPS mail, depending on EPP status. A pharmacist reviewed the medical chart of interested patients to assess if the HZV was clinically indicated; eligible patients were mailed a HZV prescription.

Arm group label: An informational packet regarding shingles and the HZV

Eligibility

Criteria:

Inclusion Criteria:

- Greater than 60 years of age

Exclusion Criteria:

- Documented herpes zoster vaccine in the EMR

Gender: All

Minimum age: 60 Years

Maximum age: N/A

Healthy volunteers: Accepts Healthy Volunteers

Overall Official
Location
facility The Ohio State University Martha Morehouse General Internal Medicine Clinic
Location Countries

United States

Verification Date

August 2018

Responsible Party

Responsible party type: Principal Investigator

Investigator affiliation: Ohio State University

Investigator full name: Stuart Beatty

Investigator title: Assistant Professor

Keywords
Has Expanded Access No
Condition Browse
Number Of Arms 2
Arm Group

Arm group label: An informational packet regarding shingles and the HZV

Arm group type: Experimental

Arm group label: Standard medical care from their primary care physician

Arm group type: No Intervention

Study Design Info

Allocation: Randomized

Intervention model: Parallel Assignment

Primary purpose: Health Services Research

Masking: None (Open Label)

Source: ClinicalTrials.gov